ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Hanmi Pharmaceutical Company Limited clinical trials

Part of Hanmi Science Co., Ltd.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 191 studies whose lead sponsor is Hanmi Pharmaceutical Company Limited. 12 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 16, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Hanmi Pharmaceutical with AstraZeneca and Novo Nordisk →

Pipeline: 12 programs

Each counted once: 12 with a study Hanmi Pharmaceutical Company Limited leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 5 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Hanmi Pharmaceutical Company Limited’s own registered studies; Hanmi Pharmaceutical Company Limited’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Hanmi Pharmaceutical Company Limited’s studies test, most open studies first — 51 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 51; every drug is on its own page, and each page lists its sponsors.

Coming up

8 of Hanmi Pharmaceutical Company Limited’s studies under way reach primary completion within a year, 3 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. 1J’27
  4. 1F
  5. 1M
  6. A
  7. M
  8. J
  9. J
  10. 1A
  11. 1S
  12. 2O
  13. 1N

Add all 8 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 20, 2026.

All 191 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now126%Recruiting 9 · Not yet recruiting 3
  • Under way, not recruiting42%
  • Completed15682%
  • Stopped early53%
  • Status unknown or other147%

Phase

Where

  • Korea, Republic of151
  • United States27
  • Germany4
  • United Kingdom3
  • Australia2
  • Czechia2

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 2015
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 626

By the year each study started; 1 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Hanmi Pharmaceutical Company Limited.

  • Hanmi Pharmaceutical Company Limited
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    191 studies

Focus areas

Conditions Hanmi Pharmaceutical Company Limited leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 191. Browse all 191 →